Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSCs in Supraspinatus Reconstruction Surgery
NCT03068988Phase 1Unknown
- Sponsor
- Nemocnice Znojmo
- Start
- Jan 2012
- Primary completion
- Dec 2014
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of mesenchymal stem cells in rotator cuff tear, sponsored by Nemocnice Znojmo. Primary endpoint: Supraspinatus tendon re-rupture rate at 2 years. Status: unknown.
02
Drugs
mesenchymal stem cells
03
Conditions
rotator cuff tear
Beyond the preview
Go deeper on NCT03068988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03068988.